In last trading session, Aptevo Therapeutics Inc (NASDAQ:APVO) saw 22.97 million shares changing hands with its beta currently measuring 6.00. Company’s recent per share price level of $1.38 trading at $0.38 or 38.26% at ring of the bell on the day assigns it a market valuation of $2.02M. That closing price of APVO’s stock is at a discount of -12957.25% from its 52-week high price of $180.19 and is indicating a premium of 31.88% from its 52-week low price of $0.94. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 2.75 million shares which gives us an average trading volume of 65.64K if we extend that period to 3-months.

Aptevo Therapeutics Inc (NASDAQ:APVO) trade information

Upright in the green during last session for gaining 38.26%, in the last five days APVO remained trading in the red while hitting it’s week-highest on Wednesday, 04/02/25 when the stock touched $1.38 price level, adding 61.77% to its value on the day. Aptevo Therapeutics Inc’s shares saw a change of -67.98% in year-to-date performance and have moved -10.39% in past 5-day. Aptevo Therapeutics Inc (NASDAQ:APVO) showed a performance of -53.22% in past 30-days. Number of shares sold short was 0.12 million shares which calculate 2.61 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 80.96% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 81.87% while estimates for its earnings growth in next 5 years are of 51.40%.

Aptevo Therapeutics Inc (NASDAQ:APVO)’s Major holders

Insiders are in possession of 0.01% of company’s total shares while institution are holding 4.85 percent of that, with stock having share float percentage of 4.85%. Investors also watch the number of corporate investors in a company very closely, which is 4.85% institutions for Aptevo Therapeutics Inc that are currently holding shares of the company.